SCHEMBL16144149

SCHEMBL16144149

COc1cccc2c1C=CN(O)C2C

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.37
GAA P10253 3/20 0.37
CYP3A4 P08684 2/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
TP53 P04637 3/20 0.36
ALDH1A1 P00352 2/20 0.36
LMNA P02545 1/20 0.36
MAPT P10636 1/20 0.36
HPGD P15428 1/20 0.36
ALOX15 P16050 1/20 0.36
ALOX12 P18054 1/20 0.36
MAPK1 P28482 1/20 0.36
HSD17B10 Q99714 1/20 0.36
MEN1 O00255 1/20 0.35
USP2 O75604 1/20 0.35
KMT2A Q03164 1/20 0.35
HTR1A P08908 4/20 0.35
HTR2C P28335 4/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17014301 0.72 CA1 (0.39) KDM4EGAACYP3A4CYP2D6CYP2C9
SCHEMBL8533808 0.69 BRD4 (0.47) KDM4EGAACYP3A4CYP2D6CYP2C9
SCHEMBL16470960 0.68 MEN1 (0.39) KDM4EGAACYP3A4CYP2D6CYP2C9
SCHEMBL15617597 0.67 KDM4E (0.37) KDM4EGAACYP3A4CYP2D6CYP2C9
Hydrochloric Acid SCHEMBL6554723 0.65 HTR2C (0.33) KDM4EGAACYP3A4CYP2D6CYP2C9
SCHEMBL8865571 0.63 SLC6A2 (0.42) KDM4EGAAALDH1A1MAPTHPGD
SCHEMBL8027390 0.62 MAOA (0.53) CYP2D6MEN1KMT2AHTR1AHTR5A
SCHEMBL8729417 0.60 ACHE (0.45)
SCHEMBL18287892 0.60 HTR2A (0.45) KDM4EGAACYP3A4CYP2D6CYP2C9
SCHEMBL31042717 0.59 KDM4E (0.39) KDM4ECYP3A4CYP2D6CYP2C19TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2601188-B1 HEPATITIS C VIRUS INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2017-10-18 EP disclosed
EP-2242751-B1 HETEROCYCLIC DERIVATIVES AS HEPATITIS C VIRUS INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2015-07-15 EP disclosed
EP-2414352-B1 HEPATITIS C VIRUS INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2014-10-01 EP disclosed